COMPANY Advanced cell / gene-based biopharmaceutical development and CDMO
CEO Message
- ENCell. Co., Ltd. Focuses on providing high quality stem cell/ gene therapy in order to improve quality of life and aims to
be the world’s best cutting-edge biopharmaceutical company. 
- ENCell Co., Ltd. aims to be the world’s most innovative R&D company developing advanced biopharmaceutical products, specializing in CDMO of biopharmaceuticals in order to contribute to a better life of the patients.
- We are more than capable of producing top-quality biopharmaceutical products, with state-of-the-art GMP facilities in compliance with KGMP standards.
ENCell Co., Ltd. is conducting stringent quality control in cell culture, refinement, analysis testing, aseptic control and refined production packaging with excellent scientific expertise. We will continue to establish and maintain the updated high-tech production equipment and facilities to meet the increasing demands for biopharmaceutical products. With our cutting-edge next-generation stem cell and gene therapy technologies, we aim to overcome the current challenges in intractable diseases and strive to become one of the most competitive biotech companies in the global market. - On behalf of our team, I would like to express my sincere gratitude for your trust and appreciation. Thank you.